Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
167.29 USD
-0.3%
Market Closed
Updated:
Apr 26, 2024
Abbvie Inc
Other Equity
|
Abbvie Inc
Other Equity Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Equity
-$2.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Equity
$33m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Equity
-$289m
|
CAGR 3-Years
34%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-9%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Equity
-$23.9m
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Equity
-$80.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-55%
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Other Equity
$4.4m
|
CAGR 3-Years
70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Other Equity?
Other Equity
-2.3B
USD
-2.3B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Equity amounts to -2.3B USD.
What is Abbvie Inc's Other Equity growth rate?
Other Equity CAGR 10Y
-18%
-18%
Over the last year, the Other Equity growth was -5%. The average annual Other Equity growth rates for Abbvie Inc have been 10% over the past three years , 1% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
